Early Treatment of Parkinson??s Disease with Cabergoline Delays the Onset of Motor Complications
- 1 January 1998
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 55 (Supplement), 23-30
- https://doi.org/10.2165/00003495-199855001-00004
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cabergoline in the treatment of early parkinson's diseaseNeurology, 1997
- Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's diseaseBMJ, 1995
- A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Wearing‐off fluctuations in Parkinson's disease: Contribution of postsynaptic mechanismsAnnals of Neurology, 1994
- Motor response to apomorphine and levodopa in asymmetric Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Neuropsychological and psychiatric side effects in the treatment of Parkinson's disease.1993
- Autonomic nervous system dysfunction in Parkinson's disease: relationships with age, medication, duration, and severity.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Long-term effects of bromocriptine given to de novo patients with idiopathic Parkinson's disease.1987
- Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography.Journal of Neurology, Neurosurgery & Psychiatry, 1986
- L-dopa treatment and Parkinson's disease.1986